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BackgroundᄏNeurocutaneous melanosis (NCM) is a rare neurocutaneous syndrome charac-
terized by the presence of multiple congenital melanocytic nevi (CMN) and the proliferation 
of melanocytes in the central nervous system, usually involving the leptomeninges. Chronic par-
tial epilepsy as a sole manifestation is rare in NCM. 
Case ReportᄏA 32-year-old man suffering from chronic partial epilepsy presented with mul-
tiple CMN on his trunk and scalp. Brain MRI demonstrated a focal lesion in the right amygdala 
that was consistent with interictal epileptiform discharges in the right temporal region on elec-
troencephalography (EEG). An anterior temporal lobectomy was performed, and the pathology 
investigation revealed numerous melanophages in the amygdala. The patient was seizure-free 
after surgery. 
ConclusionsᄏWe report a patient with NCM presenting as chronic partial epilepsy who was 
successfully treated by anterior temporal lobectomy. J Clin Neurol 2008;4:134-137
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Introduction 
 
Neurocutaneous melanosis (NCM) is a rare congenital, 
noninheritable neurocutaneous syndrome, characterized by 
the presence of large and/or multiple congenital melanocytic 
nevi (CMN) associated with melanosis or melanoma that 
usually appear in the leptomeninges. Although the clinical 
presentations of NCM vary with age, NCM is generally ac-
companied by significant neurological deficits. However, 
NCM as a cause of epilepsy without any neurological deficit 
is extremely rare. We report a case of chronic partial epilepsy 
caused by pathologically proven parenchymal NCM in the 
brain without leptomeningeal involvement, that was success-
fully treated surgically. 
 
Case Report 
 
A 32-year-old right-handed man visited our epilepsy clinic 
due to drug-resistant partial epilepsy. His seizures started at 
the age of 22 years, since when he had suffered from fre-
quent episodes of disgusting odor and light-headedness de-
spite antiepileptic drug treatment. Also, he had occasionally 
experienced motionless staring followed by generalized ton-
ic-clonic seizures when he had not complied with treatment. 
His familial and own medical histories were not remarkable, 
and the findings of a neurological examination were normal. 
Electroencephalography (EEG) showed frequent right tem-
poral sharp waves with maximal negativity in the ipsilateral 
nasopharyngeal electrode. Brain MRI showed a small focal 
lesion in the lateral part of the right amygdala. The lesion 
was hyperintense on a T2-weighted image and hypointense 
on a T1-weighted image without gadolinium enhancement 
(Fig. 1), which suggested a benign tumor.1 There were mul-
tiple large black pigmented nevi on the back, scalp, and pos-
terior neck area, which had existed from birth. The largest 
black nevus was on his back, covering 9% of his body sur-
face area (1.82 m2). 
The right temporal lobe including the amygdaloid lesion 
was excised. Intraoperative electrocorticography before re-
section revealed active spikes around the lesion. The amyg-
dala lesion was a grayish-to-black friable soft tissue without 
definite mass formation. There was no meningeal melanosis. 
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The pathology investigation of the lesion demonstrated nu-
merous melanophages. The skin biopsy of the scalp lesion 
showed that it was an intradermal nevus, as expected (Fig. 2). 
He was seizure-free (including aura) during the 15-month po-
stsurgery follow-up period. 
 
Discussion 
 
Kadonaga and Frieden2 proposed the following criteria in 
1991 that are currently used to diagnose NCM: 1) large and/ 
or multiple CMN in association with meningeal melanosis or 
melanoma; 2) no evidence of cutaneous melanoma, except 
in patients with histologically benign meningeal lesions; and 
3) no evidence of meningeal melanoma, except in patients 
with histologically benign cutaneous lesions. The second and 
third definitions exclude the possibility of metastases from 
the skin to the central nervous system (CNS) and vice versa, 
respectively. 
CMN are classified into large, medium, and small nevi ac-
cording to their size:3 larger than 20 cm in an adult, 1.5 to 
19.9 cm, and smaller than 1.5 cm, respectively. The term 
“multiple” is used when more than three lesions are present. 
Kadonaga and Freiden2 found that 66% of NCM patients 
had large nevi, and the remaining 34% had numerous pig-
mented lesions in the absence of a single large congenital 
melanocytic nevus. In their study, all NCM patients had ei-
ther posterior midline nevi or head and neck lesions, which 
suggests that the posterior axial distribution is an important 
risk factor for developing NCM. Our patient also had mul-
tiple medium-sized CMN with a posterior axial distribution. 
Embryologically, melanocytes originate from the neural 
crest and migrate to various sites in the body, such as the basal 
layer of the epidermis, pia mater, leptomeninges, medullary 
reticular formation, and substantia nigra of the midbrain.4 It 
is thought that CMN and NCM are caused by the arrest or ab-
errancy of this normal developmental pattern. In NCM, pig-
mented thickening of the leptomeninges is most frequent in 
areas with melanocytes.4 Parenchymal melanosis is less com-
mon than leptomeningeal melanosis, and caused by primary 
involvement of the melanin-containing macrophages and mel-
Fig. 1. Brain MRI. T2-weighted images 
(A, B), and T1-weighted gadolinium-en-
hancement images (C, D) show a focal 
lesion (arrow head) with hyperintensity
and hypointensity without enhancement
in the right amygdala, respectively. 
A B
C D
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anocytes, or secondary spread via Virchow-Robin spaces from 
the leptomeninges. The pathology investigation of our patient 
showed melanin-containing macrophages, and revealed paren-
chymal melanosis without leptomeningeal melanosis. 
The neurological manifestations of NCM vary with age.2 
Before the age of 2 years, the most common initial clinical 
signs and symptoms of NCM are related to increased intra-
cranial pressure, including headache (35%), vomiting (42%), 
generalized seizures (48%), increased head circumference 
(23%), cranial nerve palsies (26%; in particular VI), papille-
dema (10%), and meningeal signs (3%).6 The subset of pa-
tients with a discrete intracranial mass becomes symptomatic 
when older (mean age, 12.8 years; range, from birth to 65 
years) and is more likely to develop focal seizures, localized 
sensorimotor deficits, difficulties with speech, or psychiatric 
symptoms.6 Our patient became symptomatic with partial sei-
zures when he was 22 years old. 
The prognosis of symptomatic NCM is poor. Most of the 
33 NCM patients in a study involving giant CMN7 demon-
strated the first neurologic symptom when they were young-
er than 5 years. Eighty-two percent of the patients died by 
the time of reporting, and the median age at death was 3 years. 
However, most of the patients had diffuse leptomeningeal in-
volvement or melanoma. While symptomatic NCM is estimat-
ed to occur in less than 3% of patients with giant CMN,7 one 
study found MRI evidence of CNS melanosis in 10 (23%) of 
42 asymptomatic giant-CMN patients,8 among whom only 1 
had subsequently developed symptomatic disease during an 
average follow-up of 5 years. Because the MRI findings of 
these 10 patients showed parenchymal NCM without diffuse 
leptomeningeal involvement, the prognosis of parenchymal 
NCM appears to be much better than that of typical NCM 
with diffuse leptomeningeal involvement or melanoma. Our 
patient with parenchymal melanosis subsequently developed 
epilepsy without neurological deficits. 
Melanin pigment is inherently paramagnetic, and hence 
melanin deposits in NCM show a high signal intensity on T1- 
weighted MRI and a low signal intensity on T2-weighted MRI. 
This pattern of parenchymal melanosis appears to be most 
evident and frequent at the amygdala and adjacent anterior 
temporal cortex.8 In our patient, brain MRI showed the typ-
ical location but an atypical pattern of hyperintensity on T2-
weighted images and isointensity on T1-weighted images. 
NCM appears to be a rare cause of chronic partial epilepsy. 
Some cases with chronic epilepsy related to NCM have been 
reported, but most of them had other conditions such as CNS 
melanoma, mental retardation, psychosis, and diffuse lepto-
meningeal involvement with neurologic deficits.9 To our 
knowledge, the only surgical case with NCM similar to our 
patient was a 29-year-old woman with normal psychomotor 
development and intelligence who had right temporal-lobe 
epilepsy due to amygdaloid melanosis and underwent right 
temporal resection.10 Here we have reported a surgically suc-
cessful case of chronic partial epilepsy caused by patholo-
gically proven parenchymal NCM without leptomeningeal 
involvement. Therefore, NCM occurring in the brain paren-
chyma should be considered as a cause of chronic partial 
epilepsy. 
Fig. 2. Photograph showing the gross 
operative finding (A) of a grayish-to-
black friable soft tissue without definite 
mass formation in the right amygdala. 
The specimen from the lesion (B) con-
tained numerous melanophages in the 
cortex, which is consistent with neurocu-
taneous melanosis. The specimen from 
the scalp nevus (C, D) was compatible 
with intradermal nevus. Hematoxylin and
eosin staining. Scale bars=50 μm. 
A B 
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